Literature DB >> 16749193

Psychological distress surrounding diagnosis of malignant and nonmalignant skin lesions at a pigmented lesion clinic.

H Al-Shakhli1, D Harcourt, J Kenealy.   

Abstract

This study aimed prospectively to investigate psychological distress throughout the diagnostic process in an outpatient pigmented lesion clinic (PLC). Psychological distress was measured at pre clinical diagnosis, post clinical diagnosis, pre histological diagnosis (including a benign follow-up) and post histological diagnosis stages using standard anxiety measurement scales and a study specific measure of satisfaction with care. In total 324 patients undergoing investigation of a suspicious skin lesion consented to take part out of a cohort of 463 patients who attended the PLC in a 6 month period. Using recognised cut-off scores, 27% of women on clinic arrival reported clinically high levels of anxiety, in comparison with 10% of men (p < 0.0001). Patients given an immediate benign post clinical diagnosis reported a reduction in anxiety (p < 0.0001) but patients requiring a biopsy reported elevated levels of anxiety. Approximately, 30% of these biopsy patients reported clinically high levels of anxiety both before and after diagnosis. Patients who received a post histological diagnosis of malignant melanoma also reported the pre histological stage at the clinic as more distressing than waiting for and receiving results (p < 0.01). Patient's quality of life prior to diagnosis was excellent, but emotional functioning (p < 0.05), insomnia (p<or=0.001), and global health status (p<or=0.001) deteriorated throughout the diagnostic process for those patients who were finally diagnosed as having malignant melanoma. Patients reported high levels of satisfaction with clinic attendance and treatment, regardless of diagnosis but a need for further information was identified. This study has implications for all healthcare professionals involved in the provision of care through Pigmented Lesion Clinics in UK. The diagnostic process of a suspicious lesion is evidently a 'critical' stage requiring appropriate provision of care to meet patients' psychosocial and information needs if distress is to minimised for the large numbers of patients attending a PLC each year.

Entities:  

Mesh:

Year:  2006        PMID: 16749193     DOI: 10.1016/j.bjps.2005.01.010

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  24 in total

1.  United States Preventive Services Task Force Overstates Cosmetic Harms of Skin Cancer Screening.

Authors:  Joseph F Sobanko; Kimberly Shao; Rebecca L Pearl; Sancy Leachman
Journal:  J Clin Aesthet Dermatol       Date:  2018-04-01

2.  Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study.

Authors:  D Schadendorf; M M Amonkar; M Milhem; K Grotzinger; L V Demidov; P Rutkowski; C Garbe; R Dummer; J C Hassel; P Wolter; P Mohr; U Trefzer; C Lefeuvre-Plesse; A Rutten; N Steven; G Ullenhag; L Sherman; F S Wu; K Patel; M Casey; C Robert
Journal:  Ann Oncol       Date:  2014-02-06       Impact factor: 32.976

3.  Association of Quality of Life With Surgical Excision of Early-Stage Melanoma of the Head and Neck.

Authors:  Shoko Mori; Nina R Blank; Karen L Connolly; Stephen W Dusza; Kishwer S Nehal; Anthony M Rossi; Erica H Lee
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

4.  Health-related quality of life in patients with serious non-specific symptoms undergoing evaluation for possible cancer and their experience during the process: a mixed methods study.

Authors:  E Moseholm; S Rydahl-Hansen; B Ø Lindhardt; M D Fetters
Journal:  Qual Life Res       Date:  2016-10-04       Impact factor: 4.147

Review 5.  Assessment of patient-reported outcomes in patients with melanoma.

Authors:  Janice N Cormier; Robert L Askew
Journal:  Surg Oncol Clin N Am       Date:  2011-01       Impact factor: 3.495

6.  Prevalence of anxiety and depression and their risk factors in Chinese cancer patients.

Authors:  Jin Sheng Hong; Jun Tian
Journal:  Support Care Cancer       Date:  2013-10-04       Impact factor: 3.603

7.  Illness-related distress in women with clinically localized cutaneous melanoma.

Authors:  Thomas M Atkinson; Nikki S Noce; Jennifer Hay; Brian T Rafferty; Mary S Brady
Journal:  Ann Surg Oncol       Date:  2012-09-11       Impact factor: 5.344

8.  Relationships between patient knowledge and the severity of side effects, daily nutrient intake, psychological status, and performance status in lung cancer patients.

Authors:  J Tian; L N Jia; Z C Cheng
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

9.  Changes in quality of life after a diagnosis of cancer: a 2-year study comparing breast cancer and melanoma patients.

Authors:  M Bourdon; M Blanchin; P Tessier; M Campone; G Quéreux; F Dravet; V Sébille; A Bonnaud-Antignac
Journal:  Qual Life Res       Date:  2016-02-17       Impact factor: 4.147

Review 10.  A systematic review of health-related quality of life in cutaneous melanoma.

Authors:  D Cornish; C Holterhues; L V van de Poll-Franse; J W Coebergh; T Nijsten
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.